Their activation within the TME is driven by tumor-secreted factors such as transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), hepatocyte growth factor (HGF), and epidermal growth factor (EGF) [155]. The gene discussed is TGFB1; the disease is neoplasm.